A highly significant difference of this group of patients compared to PDGFRA and PDGFRB rearrangements is their lack of response to first- and second-generation tyrosine kinase inhibitors.
1
—
—
A highly significant difference of this group of patients compared to PDGFRA and PDGFRB rearrangements is their lack of response to first- and second-generation tyrosine kinase inhibitors.